A collaborative research team from the University of Electronic Science and Technology of China and the Hangzhou Institute of Medicine of the Chinese Academy of Sciences, proposed a novel self-supervised reconstruction framework that decouples measurement sampling resolution from reconstruction grid density to address the trade-off between sampling and imaging in single-pixel imaging. The framework enables high-pixel-resolution reconstruction from the low-dimensional measurements, providing a new strategy for overcoming resolution limitations in conventional single-pixel imaging.

Heart failure (HF) alters the bone marrow (BM), reducing protective cells that regulate inflammation, reports a study conducted at Science Tokyo. According to the study, cardiac stress reduces a population of mesenchymal stromal cells that produces heparin-binding EGF-like growth factor. The resulting reduction in protective signaling alters blood-forming stem cells and promotes inflammatory macrophages. The findings identify the BM niche as an important regulator of lasting immune changes associated with HF, suggesting potential targets for future therapies.

AUSTIN, Texas — [Thursday, October 15, 2026] — TAMEST (Texas Academy of Medicine, Engineering, Science and Technology) today announced that the late Pete Winstead and Winstead PC law firm have been selected as recipients of the 2027 Kay Bailey Hutchison Distinguished Service Award. The award recognizes their extraordinary leadership, service and enduring contributions to research, discovery and innovation in Texas.

Even a local mRNA injection can produce unwanted expression in the liver. Researchers have redesigned the lipid nanoparticles that carry mRNA to reduce this spillover in mice while preserving expression in injected muscle. The formulation also supports repeated dosing and improves the confinement of expression after local brain and eye delivery.

Umbilical cord blood is more than a source of stem cells for transplantation. A review in Science China Life Sciences examines how its diverse cells and bioactive components are being explored for cancer immunotherapy, inherited disorders and tissue repair. The authors connect these opportunities with advances in cell expansion, gene engineering and manufacturing, while identifying barriers to clinical translation. They emphasize that many emerging applications still require further evidence of safety, effectiveness and durable benefit.